Testing effectiveness (Phase 2)Study completedNCT03610724
What this trial is testing
Phase II Open Label Trial to Determine Safety & Efficacy of Tisagenlecleucel in Pediatric Non-Hodgkin Lymphoma Patients
Who this might be right for
Non-Hodgkin Lymphoma
Novartis Pharmaceuticals 34